Developmental increases in serum LH were assessed in female rhesus monkeys to test the hypotheses that (1) 
esis, serum LH in the absence of oestradiol and in response to three doses of oestradiol were compared between ovariectomized adult (n=6) and adolescent female monkeys (control group; n=6). The control females were not treated with oestradiol until serum LH had risen to within the 95% confidence interval of serum LH observed in ovariectomized adults. Doses of oestradiol achieved serum levels of approximately 80 ('low'), 160 ('intermediate') , and 250 ('high') pmol/l. For control group females, treatment with the next higher dose of oestradiol was not initiated until serum LH was no longer suppressed by the lower dose. Treatment with oestradiol produced a dose\x=req-\ dependent suppression in serum LH in adults. In contrast, low-dose oestradiol maximally suppressed serum LH throughout the initial treatment period in the control group compared with the adult females. The low oestradiol dose effectively suppressed serum LH throughout the study period in 4/6 of the control group and became ineffective at suppressing LH after 8 months of treatment in 2/6 control group females. Initiation of the intermediate dose of oestradiol to these females again maximally suppressed LH compared with adult females.
In order to determine whether IGF-I regulates this change in hypersensitivity to oestradiol negative feedback, a second group of ovariectomized, adolescent monkeys (n=6) were treated chronically with IGF-I to elevate serum IGF-I levels above those of control group females. Using the same protocol described for the control females, developmental changes in serum LH in the absence of oestradiol and in response to oestradiol negative feedback were evaluated. Treatment with IGF-I had no effect on the initial increases in serum LH occurring in the absence of oestradiol. In contrast, the decrease in hypersensitivity to the negative feedback effects of the low oestradiol dose was significantly accelerated in IGF-I-treated females, as the interval from the initiation of treatment to the point at which serum LH was no longer suppressed was shorter in IGF-I-treated (4\ m=. \ 4\ m=+-\ 0\ m=. \ 7months; mean \ m=+-\s . e . m . ) compared with control group females (8\ m=. \ 4\ m=+-\ 1\ m=. \ 9months (Plant 1986 ), a prolonged hypogonadotrophic state ensues in which LHRH and LH secretion is present but at a reduced frequency and amplitude (Watanabe & Terasawa 1989 ). This hypogonadotrophic state may be due to an active restraint (Plant & Zorub 1982) or an absence of stimulatory input (Plant et (Tanner 1978) and monkeys (Tanner et al. 1990 ), attention has focused on whether the growth hormone (GH) axis may regulate LHRH and LH release during puberty. During adolescent growth, serum GH and insulin-like growth factor-I (IGF-I) increase in response to some non-gonadal influence (Wilson 1989 , Lui et al. 1991 yet are further elevated during the peri-menarchial period as oestradiol levels increase (Mauras et al. 1987 , Wilson 1989 , Lui et al. 1991 ). Consequently, it has been proposed that factors which regulate growth may affect reproductive develop¬ ment (Bourguignon 1991 (Keppel 1980 Oestradiol produced a dose-response suppression of serum LH in adult females (Fig. 1) (73T ±8-9 pg/1; 10=7·89). During these initial low-dose oestradiol treatment regimens, serum LH did not return to 'pre-treatment' concentrations (further illustrated in Fig. 5 ).
This low-dose oestradiol treatment suppressed serum LH in 4/6 of the control females throughout the study period, representing an average of 10·0±2·0 months of treatment. However, this dose became ineffective at suppressing LH in the remaining two control females after 8-3 ±4-0 months of treatment. Unlike the initial series of low-dose oestradiol treatments (Fig. 2) , LH concentrations during the second and third week of this last low-dose treatment period were similar between adult (73T ± 8-9 pg/1) and control group females (5L6± 19-5 pg/1; 6=0·43). Once (Fig. 3) . Although the initial dose of IGF-I used (60 pg/day) elevated serum concentrations in IGF-I-treated animals above that of control group females, the dosage was increased (300 pg/day) to elevate serum IGF-I levels 50 to 75% above those in control females. Average serum IGF-I concentrations were signifi¬ cantly higher in IGF-I-treated compared with control females prior to the initiation of oestradiol treatment and during the 3 week oestradiol treatments (Fig. 3 inset Treatment with IGF-I had no effect on development changes in serum LH prior to the initiation of oestradiol treatment. The interval from ovariectomy to the initial rise in serum LH was similar in IGF-I-treated (46±09 months) and control group females (4-1 ±0-7 months; fn=0-37), as was the interval from this rise to the age at which adult-like concentrations had been attained ( Fig. 4 ; 5-0±0-8 vs 5·9±11 months; i,,=0-69). Serum LH reached levels within the 95% confidence interval for adults of similar ages for IGF-I-treated (22-5 ±1-3 months) and control females (23-8 ± 1-9 months; fn=0-14). Once it had been confirmed that serum LH had reached adult-like levels, low-dose oestradiol treatment began and this occurred at similar ages for IGF-I-treated (25-5 ±1-5 months) and control females (26-5 ±1-7 months; fn=0-46).
In contrast to these developmental changes in serum LH following ovariectomy, IGF-I treatment significantly ad¬ vanced the maturational decrease in oestradiol negative feedback inhibition (Fig. 5) . As noted above, the low-dose oestradiol treatment suppressed serum LH until the cessa¬ tion of data collection in 4/6 of the control females. In contrast, the low-dose oestradiol became ineffective at suppressing serum LH in 6/7 of the IGF-I-treated females. Since data collection was terminated prior to the release from low-dose oestradiol negative feedback for the four control and one IGF-I-treated females, age calculations for specific developmental parameters related to oestradiol negative feedback were underestimated for these animals as their age at the cessation of data collection was used for analysis (Table 1) . Nevertheless, the low oestradiol dose became ineffective at suppressing serum LH at a younger age for IGF-I-treated compared with control females (Table 1; (,,=2-54 (±0-2) months, but data collection was terminated prior to any change in LH in response to oestradiol for these animals (Fig. 5) .
Discussion
These results indicate that puberty in female monkeys is characterized by an initial increase in serum LH which The results of the present study cannot address the mechanism by which IGF-I may alter the sensitivity to oestradiol negative feedback on LH release during primate puberty. The locus of the negative feedback effects of oestradiol on LH secretion in adult female monkeys is at the level of both the hypothalamus and pituitary (Knobil 1980 , Chappel et al. 1981 , Weick et al. 1983 , Pau et al. 1990 ). With this is mind, treatment with IGF-I increases the release of LHRH from the median eminence in vitro (Hiney et al. 1991) 
